9.500GBp+5.56%Mkt Cap: 601.59M GBpP/E: —Last update: 2026-06-01
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap601.59M GBp
Enterprise Value569.40M GBp
Revenue (TTM)57.29M GBp
Gross Profit29.30M GBp
Net Income (TTM)-40.13M GBp
Revenue/Share0.0110 GBp
Last Price9.500 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees584
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-12.50
PEG—
EV/EBITDA-18.02
EV/Revenue9.94
P/S9.95
P/B90.00
EPS (TTM)-0.01
EPS (Forward)-0.01
52W Range
0.000079% of range12.10
52W High12.10 GBp
52W Low0.0000 GBp
Profitability
Gross Margin53.23%
Oper. Margin-31.35%
EBITDA Margin-55.16%
Profit Margin-72.91%
ROE142.35%
ROA-59.42%
Growth
Revenue Growth6.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.11M GBp
CapEx (TTM)3.42M GBp
FCF Margin-42.18%
FCF Yield-4.02%
Net Debt16.67M GBp
Net Debt/EBITDA-0.53
Balance Sheet
Debt/Equity-2.13
Current Ratio1.13
Quick Ratio0.70
Book Value/Sh0.0010 GBp
Cash/Share0.0020 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)13.00 GBp
Target Range13.00 GBp – 13.00 GBp
# Analysts1
Ownership
Shares Out.6.33B
Float703.13M
Insiders88.42%
Institutions0.00%
Technical
SMA 5010.25 (-7.3%)
SMA 2009.992 (-4.9%)
Beta0.89
S&P 52W Chg27.94%
Avg Vol (30d)231.08K
Avg Vol (10d)381.66K
Technical Indicators
RSI (14)37.1
MACD-0.4044
MACD Signal-0.3316
MACD Hist.-0.0728
BB Upper10.98 GBp
BB Middle9.776 GBp
BB Lower8.572 GBp
BB Width24.63%
ATR (14)1.514 GBp
Vol Ratio (20d)0.74x